home All News open_in_new Full Article
AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T
AbCellera (ABCL) will present preclinical in vivo data on its PSMA x CD3 T-cell engagers at the AACR 2025 meeting in Chicago, April 25-30. The poster presentation, titled "PSMA x CD3 T-cell engagers show preclinical efficacy for the treatment of prostate cancer" (Abstract Number 6012), will be on April 29. AbCellera's T-cell engager platform aims to improve cancer treatment by guiding the immune system to eliminate cancer cells.
The phone numbers (604)724-1242, (604)559-9005 and (778)729-9116 are also listed.
today 16 h. ago attach_file Other
attach_file
Culture
attach_file
Politics
attach_file
Other
attach_file
Economics
attach_file
Culture
attach_file
Society
attach_file
Culture
attach_file
Culture
attach_file
Economics
attach_file
Other
attach_file
Other
attach_file
Other
ID: 2026108254